D-0201-2026 Class II Ongoing

Recalled by Blossom Pharmaceuticals — Bardej, Goa

FDA drug recall D-0201-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 9600 containers.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Oct 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9600 containers

Product description

Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.

Reason for recall

cGMP deviations

Distribution pattern

USA Nationwide

Code information

Lot #: A162301, Exp. Date 9/26; A162401, Exp. Date 4/27 & A162202, Exp. Date 11/25.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0201-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0201-2026. Report a data issue: hello@regdatalab.com.